Access cutting-edge pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this La Jolla location
Preparing your pre-screening questions…
Access pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) treatment provided free
Check if you qualify for this pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) clinical trial in La Jolla, CA
No-Cost Study Care
Local to La Jolla
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients with PKP2-ACM.
Sponsor: Rocket Pharmaceuticals Inc.
Yes, this clinical trial (NCT05885412) has an active research site in La Jolla, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) treatment options in La Jolla, CA, this clinical trial (NCT05885412) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) clinical trials near you to find additional studies recruiting in your area.
See all cardiomyopathy clinical trials recruiting in La Jolla — not just this study.
Browse Cardiomyopathy Trials in La Jolla →